Screening for melas mutations in young patients with stroke of undetermined origin

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 2 B, 2007, Pages 371-376

  Conforto, Adriana Bastos ^a   Yamamoto, Fabio Iuji ^a   Oba Shinjo, Sueli Mieko ^a   Pinto, Julio Guy C ^a   Hoshino, Maurício ^a   Scaff, Milberto ^a   Marie, Suely Kazue Nagahashi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cerebrovascular disease; Cryptogenic stroke; Diagnostic methods; Mitochondrial disease; Myopathy

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MALE; MELAS SYNDROME; MYOPATHY; STROKE;

EID: 34547626393     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2007000300001     Document Type: Article

References (33)

1. Adams HP Jr., Kappelle LJ, Biller J, et al. Ischemic stroke in young adults: experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol 1995;52:491-495.
2. Kristensen B, Malm J, Carlberg B, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997;28:1702-1709.
3. Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke 2002;33:2789-2793.
4. Musolino R, La Spina P, Granata A, et al. Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc Dis 2003;15:121-128.
5. Siqueira JI Neto, Santos AC, Fabio SR, Sakamoto AC. Cerebral infarction in patients aged 15 to 40 years. Stroke 1996;27:2016-2019.
6. Martínez-Fernández E, Gil-Peralta A, García-Lozano R, et al. Mitochondrial disease and stroke. Stroke 2001;32:2507-2510.
7. Pavlakis SG, Philips PC, Dimauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488.
8. Shoffner JM. Mitochondrial myopathy diagnosis. Neurol Clin 2000;18:105-123.
9. Werneck LC, Abdalla H, Lohr A. MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes): relato de um caso. Arq Neuropsiquiatr 1987;45:288-294.
10. Pulkes Y, Seeney MG, Hanna MG. Increased risk of stroke in patients with the A12308G polymorphism in mitochondria. Lancet 2000:356:2068-2069.
11. Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesion in MELAS. Neurology 2003:61:1238-1244.
12. Marie SKN, Goto Y, Passos-Bueno MR, et al. A Caucasian family with the 3271 mutation in mitochondrial DNA. Biochem Med Biol 1994;52:136-139.
13. Adams HP, Bendixen BH, Kappelle J, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
14. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: brainstem and cerebellum. Neurology 1996;47:1125-1135.
15. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology 1998;50:1699-1708.
16. Dubowitz V. Histological and histochemical stains and reactions. In Dubowitz V, Sewry CA, Fitzsimons RB (Eds). Muscle biopsy: a practical approach. London, Bailure-Tindall; 1985:19-40.
17. The International Classification of Headache Disorders, 2.Ed. Cephalalgia 2004;24(Suppl 1):24-36.
18. Miller SA, Dykes DD, Polensky HE. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. Majamaa K, Turkka J, Karppa M, Winqvist S, Hassinen I. The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct. Neurology 1997;49:1331-1334.
20. Di Gennaro G, Buzzi MG, Ciccarelli O, et al. Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance. Headache 2000;40:568-571.
21. Rozen TD, Shanske S, Otaegui D, et al. Study of mitochondrial DNA mutations in patients with migraine with prolonged aura. Headache 2004;44:674-677.
22. Dickerson BC, Holtzman D, Grant E, Tian D. Case 36-2005: a 61-year-old woman with seizure, disturbed gait, and altered mental status. NEJM 2005;353:2271-2280.
23. Sciacco M, Prelle A, Comi GP, et al. Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation. J Neurol 2001;248:778-788.
24. Fang W, Huang CC, Lee CC, Chieng SY, Pang CY, Wei YH. Ophalmologic manifestations in MELAS syndrome. Arch Neurol 1993;50:977-980.
25. Van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek LA, et al. Mutation in mitochondrial tRNA leu (UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genetics 1992;1:368-371.
26. Melberg A, Akerlund P, RAininko R, et al. Monozygotic twins with MELAS-like syndrome lacking ragged red fibers and lactic acidaemia. Acta Neurol Scand 1996;94:233.
27. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550.
28. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy Acta Neuropathol 1987;74:226-233.
29. Kaufmann P, Shungu DC, Sano MC, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004;62:1297-1302.
30. Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamagushi T. Diffusion-weighted imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes. AJNR 2001;22:269-272.
31. Shanske S, Pancrudo J, Kaufmann P, et al. Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet 2004;130:134-137.
32. Thompson VA, Wahr JA. Anesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome. Anesth Analg 1997;85:1404-1406.
33. Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005;64:710-712.